Icahn School of Medicine at Mount Sinai
This project will evaluate MDMA Assisted Therapy (MDMA-AT) assisted psychotherapy for the treatment of Bulimia Nervosa (BN) over a 10-week period. Preliminary data suggests that MDMA can facilitate heightened openness and reduce anxiety. This study will determine whether MDMA-assisted therapy can serve as a new treatment for BN. Participants are assigned to one of three groups: MDMA-AT, MDMA-AT-BN, and Standard Treatment (ST). MDMA groups include three experimental session that include dosing, which are each followed by three integrative sessions and also include 12 psychotherapy sessions. A follow-up will take place at 6-months post baseline.
Three groups (MDMA-AT, MDMA-AT-BN, and ST) will be compared on changes in Binge Eating frequency, severity of symptoms, body image, weight, retention, acceptability of treatment, motivation, and safety. Assessments include a screening phase, baseline, MDMA-preparation phase, intervention, and a follow-up. MDMA-AT includes 3 sessions of MDMA-assisted psychotherapy, 9 integrative sessions that involve discussing the experiences during MDMA sessions and processing thoughts, emotions, and distress. Additionally, 12 weekly non-specific therapy sessions take place after the dosing and integrative se…
Inclusion Criteria: Participants will be included in the protocol if they meet the following criteria: * At least 18 years of age * Meet criteria for Bulimia Nervosa as measured by the EDA-5 * Able to provide written, informed consent * Able to swallow pills * Agree to have study visits recorded, including Experimental Sessions and non-medication therapy sessions * Provides a contact (relative, spouse, close friend or other support person) who is willing and able to be reached by the investigators in the event of a participant becoming suicidal or unreachable * Agrees to inform the investiga…
MDMA-AT assisted psychotherapy (MDMA-AT) assignment includes 3 experimental (medicine) sessions, occurring 3 weeks apart and 9 integrative sessions over the course of 10 weeks. These are followed by 12 sessions of non-specific eating disorder psychotherapy.
MDMA-AT assisted psychotherapy specific to BN (MDMA-AT-BN) assignment includes 3 experimental (medicine) sessions, occurring 3 weeks apart and 9 integrative sessions over the course of 10 weeks. These are followed by 12 sessions of BN-specific eating disorder psychotherapy.
Standard Treatment (ST) for BN assignment includes weekly therapy sessions for 22 weeks.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.